World's Best Scientists 2026 revealed!
Cora N. Sternberg

Cora N. Sternberg

Award Badge
Best Female Scientists
2025

D-Index & Metrics

Best Female Scientists

D-Index
120
Citations
79337
World Ranking
544
National Ranking
325

Medicine

D-Index
121
Citations
84976
World Ranking
3533
National Ranking
1944

Research.com Recognitions

  • 2025 - Research.com Best Female Scientists Award

Overview

Cora N. Sternberg is affiliated with Cornell University in the United States and is an active contributor to medical research, primarily within the field of Medicine. Their scientific work emphasizes oncology with significant involvement in pulmonary and respiratory medicine, surgery, cancer research, radiology, nuclear medicine, and imaging. The subfields align closely with their main research focus on cancer and related treatments.

Their publication record features several recent papers spanning advanced cancer therapies and clinical oncology. Notable publications include:

  • Avelumab Maintenance Therapy for Advanced or Metastatic Urothelial Carcinoma, 2020, New England Journal of Medicine
  • Rucaparib in Men With Metastatic Castration-Resistant Prostate Cancer Harboring a BRCA1 or BRCA2 Gene Alteration, 2020, Journal of Clinical Oncology
  • TROPHY-U-01: A Phase II Open-Label Study of Sacituzumab Govitecan in Patients With Metastatic Urothelial Carcinoma Progressing After Platinum-Based Chemotherapy and Checkpoint Inhibitors, 2021, Journal of Clinical Oncology
  • Enzalutamide and Survival in Nonmetastatic, Castration-Resistant Prostate Cancer, 2020, New England Journal of Medicine
  • Adjuvant atezolizumab versus observation in muscle-invasive urothelial carcinoma (IMvigor010): a multicentre, open-label, randomised, phase 3 trial, 2021, The Lancet Oncology

The scope of research touches on key topics such as:

  • Prostate Cancer Treatment and Research
  • Bladder and Urothelial Cancer Treatments
  • Cancer Immunotherapy and Biomarkers
  • Radiopharmaceutical Chemistry and Applications
  • Urinary and Genital Oncology Studies
  • Cancer, Lipids, and Metabolism
  • Renal Cell Carcinoma Treatment

Frequent coauthors contributing alongside Sternberg include Scott T. Tagawa, David M. Nanus, Ana M. Molina, Karim Fizazi, and Yohann Loriot, indicating collaborative contributions within the oncology research community.

Their publications are primarily found in journals with a strong clinical oncology and cancer focus, such as:

  • Journal of Clinical Oncology
  • Annals of Oncology
  • Bladder Cancer
  • European Urology
  • The Journal of Urology

Best Publications

  • Increased Survival with Enzalutamide in Prostate Cancer after Chemotherapy

    Howard I. Scher;Karim Fizazi;Fred Saad;Mary-Ellen Taplin

  • Abiraterone and Increased Survival in Metastatic Prostate Cancer

    Johann S. de Bono;Christopher J. Logothetis;Arturo Molina;Karim Fizazi

  • Enzalutamide in Metastatic Prostate Cancer before Chemotherapy

    Tomasz M Beer;Andrew J Armstrong;Dana E Rathkopf;Yohann Loriot

  • Pembrolizumab as Second-Line Therapy for Advanced Urothelial Carcinoma

    Joaquim Bellmunt;Ronald De Wit;David J. Vaughn;Yves Fradet

  • Pazopanib in Locally Advanced or Metastatic Renal Cell Carcinoma: Results of a Randomized Phase III Trial

    Cora N. Sternberg;Ian D. Davis;Jozef Mardiak;Cezary Szczylik

  • Long-term results with immediate androgen suppression and external irradiation in patients with locally advanced prostate cancer (an EORTC study): a phase III randomised trial.

    Michel Bolla;Laurence Collette;Léo Blank;Padraig Warde

  • Pazopanib versus Sunitinib in Metastatic Renal-Cell Carcinoma

    Robert J. Motzer;Thomas E. Hutson;David Cella;James Reeves

  • Design and end points of clinical trials for patients with progressive prostate cancer and castrate levels of testosterone: recommendations of the Prostate Cancer Clinical Trials Working Group.

    Howard I. Scher;Susan Halabi;Ian Tannock;Michael Morris

  • Improved Survival in Patients with Locally Advanced Prostate Cancer Treated with Radiotherapy and Goserelin

    Michel Bolla;Dionisio Gonzalez;Padraig Warde;Jean Bernard Dubois

  • Trial Design and Objectives for Castration-Resistant Prostate Cancer: Updated Recommendations From the Prostate Cancer Clinical Trials Working Group 3

    Howard I. Scher;Michael J. Morris;Walter M. Stadler;Celestia Higano

  • Nanoliposomal irinotecan with fluorouracil and folinic acid in metastatic pancreatic cancer after previous gemcitabine-based therapy (NAPOLI-1): a global, randomised, open-label, phase 3 trial

    Andrea Wang-Gillam;Chung-Pin Li;György Bodoky;Andrew Dean

  • Abiraterone acetate for treatment of metastatic castration-resistant prostate cancer: final overall survival analysis of the COU-AA-301 randomised, double-blind, placebo-controlled phase 3 study

    Karim Fizazi;Howard I. Scher;Arturo Molina;Christopher J. Logothetis

  • Effect of Granulocyte Colony-Stimulating Factor on Neutropenia and Associated Morbidity Due to Chemotherapy for Transitional-Cell Carcinoma of the Urothelium

    J.L. Gabrilove;J.L. Gabrilove;A. Jakubowski;A. Jakubowski;H. Scher;H. Scher;C. Sternberg;C. Sternberg

  • Abiraterone acetate plus prednisone versus placebo plus prednisone in chemotherapy-naive men with metastatic castration-resistant prostate cancer (COU-AA-302): final overall survival analysis of a randomised, double-blind, placebo-controlled phase 3 study

    Charles J. Ryan;Matthew R. Smith;Karim Fizazi;Fred Saad

  • Avelumab Maintenance Therapy for Advanced or Metastatic Urothelial Carcinoma

    Thomas Powles;Se Hoon Park;Eric Voog;Claudia Caserta

  • External irradiation with or without long-term androgen suppression for prostate cancer with high metastatic risk: 10-year results of an EORTC randomised study

    Michel Bolla;Geertjan Van Tienhoven;Padraig Warde;Jean Bernard Dubois

  • Enzalutamide in men with nonmetastatic, castration-resistant prostate cancer

    Maha Hussain;Karim Fizazi;Fred Saad;Per Rathenborg

  • Cabozantinib versus everolimus in advanced renal cell carcinoma (METEOR): final results from a randomised, open-label, phase 3 trial

    Toni K Choueiri;Bernard Escudier;Thomas Powles;Nizar M Tannir

  • Preliminary Results of M-VAC (Methotrexate, Vinblastine, Doxorubicin and Cisplatin) for Transitional Cell Carcinoma of the Urothelium

    Cora N. Sternberg;Cora N. Sternberg;Cora N. Sternberg;Alan Yagoda;Alan Yagoda;Alan Yagoda;Howard I. Scher;Howard I. Scher;Howard I. Scher;Robin C. Watson;Robin C. Watson;Robin C. Watson

  • Postoperative radiotherapy after radical prostatectomy for high-risk prostate cancer: long-term results of a randomised controlled trial (EORTC trial 22911)

    Michel Bolla;Hein van Poppel;Bertrand Tombal;Kris Vekemans

Frequent Co-Authors

Joaquim Bellmunt
Joaquim Bellmunt Beth Israel Deaconess Medical Center
Fred Saad
Fred Saad University of Montreal
Karim Fizazi
Karim Fizazi University of Paris-Saclay
Howard I. Scher
Howard I. Scher Memorial Sloan Kettering Cancer Center
Bertrand Tombal
Bertrand Tombal Université Catholique de Louvain
Thomas Powles
Thomas Powles Queen Mary University of London
Johann S. de Bono
Johann S. de Bono Institute of Cancer Research
Toni K. Choueiri
Toni K. Choueiri Harvard University
Celestia S. Higano
Celestia S. Higano University of Washington
Tomasz M. Beer
Tomasz M. Beer Oregon Health & Science University

If you think any of the details on this page are incorrect, let us know.

Report an issue

We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below:

Related Online Degrees & Career Pathways

If you’re exploring medicine in the USA, there are diverse online nursing and healthcare programs to consider. Many students look at how much does online nursing school cost as affordability is a critical factor. Accredited online nursing programs can offer flexibility and reduced expenses compared to traditional on-campus options.

For those already holding an RN license, advancing your qualifications can be quicker and more affordable with the cheapest rn to bsn program choices. These programs help RNs transition to a BSN for higher earning potential and expanded career paths.

If your career goals include leadership roles or research, pursuing an advanced degree like an online phd in nursing can open new doors. These programs are designed for nurses aiming to reach the highest levels of expertise, often at a more manageable cost thanks to online options.

Even if you come from a non-nursing background, options such as online direct entry msn programs for non-nursing majors can fast-track your entry into the nursing profession. These programs provide an accelerated pathway, making a healthcare career more accessible than ever.

Best Scientists Citing Cora N. Sternberg

Trending Scientists